Women with pathologic variants of different breast cancer genes, such as BRCA1/2, TP53 and PTEN, have a higher lifetime risk of developing breast cancer in comparison to the overall population (2, –4), and are, depending on the risk profile, recommended annual surveillance or prophylactic surgery (1). This evidence concerns the gene BRCA1 and breast carcinoma.